This activity is supported by an educational grant from Bristol-Myers Squibb.

Advances in Collaborative Practice for Patients with Head and Neck Cancers

Robert Haddad, MD
Dana-Farber Cancer Institute

Jason Glass, ACNP-BC
Dana-Farber Cancer Institute

Head and neck cancer care is complex, and there are limited treatment options; over the past decade only one new therapy received FDA approval. However, as in other tumor types, the landscape is changing with the recent emergence of newer targeted therapies and immunotherapies. This learning activity will provide advanced practitioners with valuable updates on screening and prevention, the risk associated with human papillomavirus (HPV), treatment options, mechanisms of action for new therapies, and monitoring for and the management of adverse events.


Download Podcast


Download Transcript


Download Slides


Download Slides & Transcripts


These CME/CE/CPE accredited activities are jointly provided by

JADPRO CE Logo Harborside Press Logo APSHO Logo Annenberg Logo
Copyright © 2010-2020 Harborside Press, LLC All rights reserved.               
Home | Current Issue | Previous Issue | Submissions | About JADPRO | Advertising | Privacy Policy | Contact | Copyright Notice/Disclaimer | Subscribe
Bot trap - Don't go here
By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.